potential COVID-19 treatments living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	COVID-19 (hospitalized or not)
potential COVID-19 treatments
adjuvant therapies
anticoagulant	HEP-COVID
anti-inflammatoty and immuno-therapy
corticosteroids	Husain
Immunostimulants drugs
levamisole	Roostaei
Immunosuppressants drugs
anti-interleukin-6
tocilizumab	Hong Zhao
antiviral and associated therapy
doxycycline	Husain
ivermectin	NCT04429711 ...
zinc	Abd-Elsalam

5348	Reynolds (COVID positive patient), 2020	1	13	3		not a RCT	high risk of bias
5399	Northwell Consortium (Richardson), 2020	0	99	0	selection pending
5903	Anzola, 2020	0	10	0	selection pending
6660	Bae, 2021	0	12	0	selection pending
8313	Bahl (Fully vaccinated vs unvaccinated), 2021	0	10	0	selection pending